Summit Trail Advisors’s PetMed Express PETS Stock Holding History

Summit Trail Advisors’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-24	Closed	-$1K	–	1315
2017 Q4	$1K	Buy	+24	New	+$946	﹤0.01%	1841

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Summit Trail Advisors's PETS Position: Q1 2018 in Review

Summit Trail Advisors sold out of PetMed Express (PETS) in Q1 2018, closing a stake of 24 shares — an estimated $1K sold.

Summit Trail Advisors first reported a position in PETS in Q4 2017 and held it in 1 quarter. The position peaked at $1K in Q4 2017. 205 funds tracked by Wall St. Rank hold PETS as of Q1 2018.

Summit Trail Advisors reported no remaining PetMed Express position as of Q1 2018 after selling out during the quarter.
Summit Trail Advisors sold 24 PetMed Express shares in Q1 2018, an estimated $1K.
Summit Trail Advisors first reported a position in PetMed Express in Q4 2017 and held it in 1 quarter.
Summit Trail Advisors's PetMed Express position peaked at $1K in Q4 2017.
205 funds tracked by Wall St. Rank held PetMed Express as of Q1 2018.

Based on Summit Trail Advisors's 13F filing for Q1 2018, filed 21 May 2018.